Mackenzie Financial Corp Boosts Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Mackenzie Financial Corp raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 58.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,807,407 shares of the company’s stock after purchasing an additional 664,979 shares during the period. Mackenzie Financial Corp’s holdings in HealthEquity were worth $119,831,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HQY. FMR LLC boosted its stake in shares of HealthEquity by 19.1% during the 3rd quarter. FMR LLC now owns 5,648,992 shares of the company’s stock worth $412,659,000 after purchasing an additional 907,743 shares during the last quarter. Norges Bank acquired a new stake in shares of HealthEquity in the fourth quarter worth approximately $34,071,000. BlackRock Inc. boosted its position in shares of HealthEquity by 4.0% in the first quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock worth $635,488,000 after acquiring an additional 358,743 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of HealthEquity by 15.5% in the first quarter. JPMorgan Chase & Co. now owns 2,474,430 shares of the company’s stock worth $145,273,000 after acquiring an additional 331,735 shares during the last quarter. Finally, Invesco Ltd. boosted its position in shares of HealthEquity by 164.6% in the third quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock worth $35,359,000 after acquiring an additional 301,078 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Up 0.5 %

HQY opened at $80.23 on Tuesday. The firm has a market capitalization of $6.88 billion, a P/E ratio of 125.36, a P/E/G ratio of 1.30 and a beta of 0.53. The firm’s 50 day moving average is $80.90 and its 200-day moving average is $74.08. HealthEquity, Inc. has a 52-week low of $48.86 and a 52-week high of $84.49. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. Analysts expect that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Insider Activity

In related news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares in the company, valued at $10,106,739.35. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares in the company, valued at $10,106,739.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the business’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the sale, the director now owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Insiders have sold 71,322 shares of company stock worth $5,682,895 over the last 90 days. Company insiders own 2.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on HQY shares. KeyCorp raised their target price on shares of HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, March 22nd. JMP Securities started coverage on shares of HealthEquity in a research report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 target price on the stock. Bank of America raised their target price on shares of HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. BTIG Research raised their target price on shares of HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Finally, Barclays lifted their price target on shares of HealthEquity from $84.00 to $104.00 and gave the company an “overweight” rating in a research report on Friday, February 23rd. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.